| Released | Contributor | Author | Title | Pages | Price |
| 29-Nov-2009 | PriceTarget Research, Inc. |
N/A
| Alcon has a current Overall Rating of A (Highest Rating). | 7 |
$25 |
| 25-Nov-2009 | New Constructs, LLC |
N/A
| ACL: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings | 19 |
$10 |
| 25-Nov-2009 | Directors Deals Ltd. | Company Snapshot | Company Snapshot - ACAL | 1 |
$10 |
| 24-Nov-2009 | ValuEngine, Inc. |
N/A
| ValuEngine Industry Report for MEDICAL SUPPLIES | 18 |
$49 |
| 23-Nov-2009 | PriceTarget Research, Inc. |
N/A
| NYSE US 100 Intelligence Monitor: overall outlook NEUTRAL - 14 new Leaders; 17 new Laggards. | 46 |
$40 |
| 23-Nov-2009 | Reuters Investment Profile |
N/A
| Alcon Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. | 12 |
$20 |
| 23-Nov-2009 | Plunkett Research, Ltd. | Jack W. Plunkett | Engineering & Research Industry Trends, Statistics & Analysis 2009 (Summary) | 70 |
$199 |
| 23-Nov-2009 | Plunkett Research, Ltd. | Jack W. Plunkett | Health Care Industry Trends, Statistics & Analysis 2010 (Summary) | 98 |
$199 |
| 23-Nov-2009 | Plunkett Research, Ltd. | Jack W. Plunkett | Health Care Industry Market Research and Competitive Analysis 2010 | 730 |
$299 |
| 23-Nov-2009 | Plunkett Research, Ltd. | Jack W. Plunkett | Biotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary) | 71 |
$199 |
0.29% Nasdaq 
Research Reports
